Zentalis Pharma Says FDA Grants Fast Track Status on Azenosertib Cancer Drug Candidate

In This Article:

Zentalis Pharmaceuticals (ZNTL) said Thursday the US Food and Drug Administration granted fast track

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.